65219-510-20 : NDC 2026 Code

65219-510-20 : Potassium Acetate ( Potassium Acetate )

Additionally :

You can get information about “65219-510-20” NDC code in 65219-510-20 in HTML format

HTML | 65219-510-20 in TXT (Plain Text) format

TXT | 65219-510-20 in PDF (Portable Document Format)

PDF | 65219-510-20 in XML format

XML formats.

NDC Code : 65219-510-20 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "65219-510-20",
    "PackageDescription": "25 VIAL, SINGLE-DOSE in 1 TRAY (65219-510-20)  / 20 mL in 1 VIAL, SINGLE-DOSE (65219-510-02) ",
    "NDC11Code": "65219-0510-20",
    "ProductNDC": "65219-510",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Potassium Acetate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Potassium Acetate",
    "DosageFormName": "INJECTION, SOLUTION, CONCENTRATE",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20241127",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA217515",
    "LabelerName": "Fresenius Kabi USA, LLC",
    "SubstanceName": "POTASSIUM ACETATE",
    "StrengthNumber": "3.93",
    "StrengthUnit": "g/20mL",
    "Pharm_Classes": "Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-12-13",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20241127",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}